Lawrence Lamb's most recent trade in IN8bio Inc was a trade of 1,639 Series B Warrants (right to buy) done . Disclosure was reported to the exchange on April 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 1,639 | 1,639 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Apr 2025 | 1,639 | 0 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 306,750 | 306,750 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 286,899 | 286,899 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP AND CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 169,000 | 169,000 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Lamb Lawrence | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 1,639 | 1,639 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 1,639 | 1,639 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Lamb Lawrence | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 1,639 | 101,369 | - | - | Common Stock | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 77,600 | 77,600 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 62,826 | 62,826 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 16 Aug 2022 | 526 | 99,730 | - | 1.9 | 999 | Common Stock |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share. | 05 May 2022 | 26,204 | 99,204 | - | 1.1 | 27,999 | Common Stock |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2022 | 26,204 | 1,171 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 22,082 | 83,582 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Lawrence Lamb | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2021 | 61,500 | 61,500 | - | - | Employee Stock Option (right to buy) |